Secure shopping
EMIS Insights Industry Reports
EMIS Insights, our proprietary research arm, provides comprehensive industry reports on key emerging markets. Our network of locally based industry experts supplies analysis exclusive to EMIS customers.
Each report contains in-depth analysis of the sector’s importance for the country’s economy, detailed statistics and infographics. The report’s contents include executive summary, sector and subsector overviews, competitive and regulatory environment, as well as thorough company profiles of the top market players.
The Philippines pharmaceuticals and healthcare sector is entering a phase of accelerated growth. The Philippines economy has grown considerably over the recent years, creating a growing middle-class population with the means to access ...
View more details
The SEA region has had an admirable record in improving its record against infectious diseases over the nearly three decades from 1990 to 2019. The region’s rapid economic growth relative to the rest of the world has contributed to ...
View more details
Indonesia’s pharmaceuticals and healthcare sector is one of the fastest-growing in the ASEAN region. The Indonesian government has prioritised widening healthcare access and increasing the healthcare system’s capacity since 2014. However, ...
View more details
After a slowdown in FY2020 due to dampened economic activity and deleveraging of corporate balance sheets, total assets of the banking sector in Q3 FY2021 slightly grew by 2% q/q. Bank credits (or “loans and advances” as the ...
View more details
In Q3 FY2021, the automotive output volume in India (excluding commercial vehicles) reached 7mn units. On a quarterly basis, production increased by 8.3% in Q3 FY2021 (up from 6.5mn units in Q2 FY2021, excluding commercial vehicles). Along this ...
View more details
Malaysia has one of the ASEAN region’s most developed pharmaceuticals and healthcare sectors. Malaysia has a two-tiered system in which the government, under the Ministry of Health, operates healthcare facilities and regulates medical practice ...
View more details
Latin America was among the hardest-hit regions by the COVID-19 pandemic. The novel coronavirus entered the region at a bad time. The commodities boom at end of the 2000s combined with several local crises afterwards have hurt badly the public ...
View more details
Although Thailand’s pharmaceuticals and healthcare sector has developed considerably over the past few decades, there is still considerable runway for further growth. Thailand stands out amongst emerging market countries for offering universal ...
View more details
The COVID-19 pandemic and the related containment measures – including full-scale lockdowns and other restrictions throughout 2020 – had an unprecedented impact on both car supply and demand across the global automotive market. ...
View more details
Colombia was the fourth-largest pharmaceutical market in Latin America in terms of sales volume in 2019, with a large and growing population, a universal but underfunded social security health insurance system, and a small but rapidly ...
View more details